RAPAFLO (Physicians Total Care, Inc.)


Welcome to the PulseAid listing for the RAPAFLO drug offered from Physicians Total Care, Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Physicians Total Care, Inc.
NON-PROPRIETARY NAME: silodosin
SUBSTANCE NAME: SILODOSIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-09-15
END MARKETING DATE: 0000-00-00


RAPAFLO HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRAPAFLO from Physicians Total Care, Inc.
LABELER NAME: Physicians Total Care, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 8(mg/1)
START MARKETING DATE: 2010-09-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54868-6173_9a9ef99a-a794-43c0-ba3e-169752985a92
PRODUCT NDC: 54868-6173
APPLICATION NUMBER: NDA022206

Other SILODOSIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.RAPAFLO
Avera McKennan HospitalRAPAFLO
Physicians Total Care, Inc.RAPAFLO